The University of California, Davis (UC Davis) and the University of Colorado Anschutz Medical Campus have received a $2.7m (~£2.15m) grant from the National Institute on...
Beckley Psytech and Empatica are collaborating to support the collection and analysis of data in Beckley Psytech’s future clinical trials.
Drug developer Benuvia has received approval from the DEA to manufacture psychedelic Active Pharmaceutical Ingredients (APIs).
In recent weeks, much has been made of psychedelic drugs’ potential to redefine mental health treatment.
Policy specialists PsychedelicsEUROPE and biopharma company, Mycotopia Therapies, are partnering to explore opportunities for psychedelic care on the continent.
As research into psychedelics continues to grow, a new peer reviewed scientific journal – Psychedelic Medicine – will be launched in 2023 to provide a high-profile...
Nirvana Life Sciences has announced it is making progress with its Health Canada Dealer’s licence application and its facility development.
In 1943, Swiss chemist Albert Hofmann took the first LSD trip – what is it looking like for the compound today?
SABI Mind and Reverie Psychedelics have partnered to expand research into psychedelic-assisted therapies.
Delic Holdings Corp subsidiary, Delic Labs, has received a Health Canada 56 Research Exemption that will allow scientists to conduct research and perform tests on psychedelic and...
